• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较研究依非贝特、烟酸和氯贝丁酯在大鼠体内和体外的抗脂解作用。

Comparative study on the in vivo and in vitro antilipolytic effects of etofibrate, nicotinic acid and clofibrate in the rat.

机构信息

Facultad de Ciencias Experimentales y Técnicas, Universidad San Pablo-CEU, P.O. Box 67, 28660 Boadilla del Monte, Madrid, Spain.

出版信息

Environ Toxicol Pharmacol. 1996 Dec 20;2(4):351-7. doi: 10.1016/s1382-6689(96)00069-5.

DOI:10.1016/s1382-6689(96)00069-5
PMID:21781742
Abstract

The release of both glycerol and free fatty acids (FFA) into a medium by epididymal fat pad pieces from fed rats incubated in Krebs Ringer bicarbonate-albumin buffer supplemented or not with epinephrine decreased more in the presence of etofibrate than in the presence of equimolecular doses of nicotinic acid or clofibrate. The first drug was the only one to stimulate the rate of fatty acid re-esterification when incubations were done under basal conditions. By 3 h after their acute oral administration all three drugs decreased plasma FFA levels, although the effect from etofibrate was largest, the drugs enhanced or decreased plasma glycerol levels depending on both the dose and the time after treatment. Plasma triglycerides also decreased at 3 h after oral drug administration, and this effect was similar with etofibrate and nicotinic acid but less with clofibrate. With the exception of a decrease at 7 h after the highest dose (1.2 mmol/kg) of either etofibrate or nicotinic acid (but not clofibrate), plasma cholesterol levels remained stable at 7 h after the respective treatments. Thus, the hypocholesterolemic effect of these drugs seems secondary to their hypotriglyceridemic effect, which would be a consequence of their respective antilipolytic actions, and follows an efficiency sequence of etofibrate, nicotinic acid and clofibrate.

摘要

用 Krebs-Ringer 重碳酸盐-白蛋白缓冲液培养的 fed 大鼠附睾脂肪垫组织,在添加或不添加肾上腺素的情况下,释放甘油和游离脂肪酸 (FFA) 进入培养基,在 presence of etofibrate 的情况下比在 equimolecular doses of nicotinic acid 或 clofibrate 中的情况下减少得更多。当在基础条件下进行孵育时,第一种药物是唯一一种刺激脂肪酸再酯化速率的药物。在急性口服给药后 3 小时,所有三种药物都降低了血浆 FFA 水平,尽管 etofibrate 的效果最大,但药物根据剂量和治疗后时间的不同,会增加或降低血浆甘油水平。口服药物后 3 小时,血浆甘油三酯也降低,这种效果与 etofibrate 和烟酸相似,但与 clofibrate 不同。除了在最高剂量(1.2 mmol/kg)的 etofibrate 或烟酸(但不是 clofibrate)后 7 小时降低之外,血浆胆固醇水平在各自治疗后 7 小时保持稳定。因此,这些药物的降胆固醇作用似乎是其降甘油三酯作用的次要作用,这是它们各自的抗脂肪分解作用的结果,并且遵循 etofibrate、烟酸和 clofibrate 的效率顺序。

相似文献

1
Comparative study on the in vivo and in vitro antilipolytic effects of etofibrate, nicotinic acid and clofibrate in the rat.比较研究依非贝特、烟酸和氯贝丁酯在大鼠体内和体外的抗脂解作用。
Environ Toxicol Pharmacol. 1996 Dec 20;2(4):351-7. doi: 10.1016/s1382-6689(96)00069-5.
2
Studies with etofibrate in the rat. Part II: A comparison of the effects of prolonged and acute administration on plasma lipids, liver enzymes and adipose tissue lipolysis.依托贝特对大鼠的研究。第二部分:长期给药与急性给药对血脂、肝酶及脂肪组织脂解作用的比较。
Biochim Biophys Acta. 1993 Jul 1;1168(3):340-7. doi: 10.1016/0005-2760(93)90191-b.
3
Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism.依托贝特对大鼠的研究。第一部分:对甘油、游离脂肪酸和三酰甘油代谢的影响。
Biochim Biophys Acta. 1988 Nov 4;963(1):42-52. doi: 10.1016/0005-2760(88)90336-0.
4
Pantethine stimulates lipolysis in adipose tissue and inhibits cholesterol and fatty acid synthesis in liver and intestinal mucosa in the normolipidemic rat.泛硫乙胺可刺激脂肪组织的脂肪分解,并抑制正常血脂大鼠肝脏和肠黏膜中的胆固醇和脂肪酸合成。
Environ Toxicol Pharmacol. 1998 Aug 4;6(1):59-66. doi: 10.1016/s1382-6689(98)00020-9.
5
Bioavailability studies of etofibrate in rhesus monkeys.益多酯在恒河猴体内的生物利用度研究。
Arzneimittelforschung. 1985;35(2):489-92.
6
Inhibition of rat and human adipocyte adenylate cyclase in the antilipolytic action of insulin, clofibrate, and nicotinic acid.胰岛素、氯贝丁酯和烟酸在抗脂解作用中对大鼠和人脂肪细胞腺苷酸环化酶的抑制作用。
Can J Biochem. 1979 Aug;57(8):1058-63. doi: 10.1139/o79-134.
7
Effect of etofibrate on bile production in the normolipidemic rat.益多酯对正常血脂大鼠胆汁生成的影响。
Gen Pharmacol. 1995 May;26(3):537-42. doi: 10.1016/0306-3623(94)00225-c.
8
[Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].益多酯与氯贝丁酯对血清脂质水平升高患者的双盲试验(作者译)
Dtsch Med Wochenschr. 1975 Nov 28;100(48):2486-8. doi: 10.1055/s-0028-1106571.
9
[The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].益多酯对血清胆固醇及甘油三酯的影响(作者译)
Med Klin. 1979 Jun 1;74(22):875-6.
10
Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs.益多酯、氯贝酸和烟酸酯及其产物在犬体内的处置情况。
J Pharm Sci. 1985 Mar;74(3):295-9. doi: 10.1002/jps.2600740314.

引用本文的文献

1
Treatment of lactating sows with clofibrate as a synthetic agonist of PPARα does not influence milk fat content and gains of litters.用氯贝丁酯作为过氧化物酶体增殖物激活受体α(PPARα)的合成激动剂治疗泌乳母猪,不会影响乳脂含量和仔猪体重增加。
BMC Vet Res. 2015 Mar 7;11:54. doi: 10.1186/s12917-015-0368-y.
2
Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats.在非诺贝特治疗的妊娠大鼠中,甘油三酯血症与过氧化物酶体增殖物激活受体-α表达并无关联。
Mol Cell Biochem. 2005 May;273(1-2):97-107. doi: 10.1007/s11010-005-8145-z.